More recently, the SUMMIT trial demonstrated that tirzepatide reduced the composite risk of cardiovascular death or worsening heart failure by 38% (HR = 0.62, 95% CI: 0.410.95) in patients with heart failure with preserved ejection fraction (HFpEF) and a BMI 30 kg/m 2 , 32% of whom also had type 2 diabetes
Once-weekly Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine 384(11) 2021PMID: 33567185 NEJM 4 Jastreboff AM, Aronne LJ, Ahmad NN, et al
As a bonus, its also good for bone healthanother risk of significant weight loss." Other ingredients Jacques recommended are vitamins A and C, zinc, niacin, CoQ10, astaxanthin and Pycnogenol, as well as other polyphenols such as those from green tea and cocoa
fast digestion
Even when GLP-1 medications are appropriate, the supervision piece becomes more important, not less